Bruker Corp (BRKR)
70.67
+0.23
(+0.33%)
USD |
NASDAQ |
Sep 27, 16:00
70.73
+0.06
(+0.08%)
After-Hours: 20:00
Bruker SG&A Expense (TTM): 805.40M for June 30, 2024
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
Date | Value |
---|---|
June 30, 2024 | 805.40M |
March 31, 2024 | 762.30M |
December 31, 2023 | 730.10M |
September 30, 2023 | 685.40M |
June 30, 2023 | 652.90M |
March 31, 2023 | 627.60M |
December 31, 2022 | 610.80M |
September 30, 2022 | 600.30M |
June 30, 2022 | 596.50M |
March 31, 2022 | 578.70M |
December 31, 2021 | 564.60M |
September 30, 2021 | 542.80M |
June 30, 2021 | 516.40M |
March 31, 2021 | 485.10M |
December 31, 2020 | 477.80M |
September 30, 2020 | 476.10M |
June 30, 2020 | 487.10M |
March 31, 2020 | 508.70M |
December 31, 2019 | 504.20M |
September 30, 2019 | 494.60M |
June 30, 2019 | 476.10M |
March 31, 2019 | 462.90M |
December 31, 2018 | 453.10M |
September 30, 2018 | 443.30M |
June 30, 2018 | 440.00M |
Date | Value |
---|---|
March 31, 2018 | 432.40M |
December 31, 2017 | 420.20M |
September 30, 2017 | 410.50M |
June 30, 2017 | 403.20M |
March 31, 2017 | 399.80M |
December 31, 2016 | 394.40M |
September 30, 2016 | 393.40M |
June 30, 2016 | 393.10M |
March 31, 2016 | 390.70M |
December 31, 2015 | 402.80M |
September 30, 2015 | 418.40M |
June 30, 2015 | 430.20M |
March 31, 2015 | 447.30M |
December 31, 2014 | 454.20M |
September 30, 2014 | 454.70M |
June 30, 2014 | 452.80M |
March 31, 2014 | 446.70M |
December 31, 2013 | 444.00M |
September 30, 2013 | 440.70M |
June 30, 2013 | 440.20M |
March 31, 2013 | 443.50M |
December 31, 2012 | 441.40M |
September 30, 2012 | 446.90M |
June 30, 2012 | 443.10M |
March 31, 2012 | 428.50M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (TTM) Range, Past 5 Years
476.10M
Minimum
Sep 2020
805.40M
Maximum
Jun 2024
585.37M
Average
571.65M
Median
SG&A Expense (TTM) Benchmarks
Bio-Rad Laboratories Inc | 817.95M |
Azenta Inc | 305.65M |
Harvard Bioscience Inc | 45.99M |
Bionano Genomics Inc | 71.68M |
Akoya Biosciences Inc | 76.87M |